GlassScriptPhysician profile
Liberty Liboon Dizon
NPI 1417026063
$3,994.26
in general payments reported to CMS, 2019-2025
36 companies · $658 in 2025
The $658 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,031 · 2020: $374 · 2021: $456 · 2022: $609 · 2023: $415 · 2024: $451 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $558.79 | 2019-2021 | |
| Novo Nordisk INC | $501.57 | 2019-2023 | Rybelsus |
| Supernus Pharmaceuticals, INC. | $425.42 | 2021-2025 | Qelbree, Qelbree |
| Amgen INC. | $315.28 | 2022-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $292.50 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Ironshore Pharmaceuticals INC. | $213.05 | 2019-2024 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $147.96 | 2024-2025 | Ycanth |
| Corium, LLC | $138.99 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2025 | Breztri |
| Biogen, INC. | $124.97 | 2019 | |
| Merck Sharp & Dohme LLC | $96.04 | 2021-2024 | Verquvo, Vaxneuvance, Gardasil 9 |
| Cranial Technologies, INC | $94.05 | 2020-2023 | Doc Band |
| Cequr Corporation | $81.14 | 2025 | Cequr Simplicity |
| Tris Pharma INC | $78.21 | 2019-2024 | Dyanavel Xr |
| Alk-Abello, INC | $74.71 | 2024-2025 | Neffy, Odactra, Grastek |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $71.00 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $69.38 | 2019-2021 | |
| Vapotherm INC | $66.67 | 2019 | |
| Xeris Pharmaceuticals, INC. | $51.37 | 2021 | |
| Pfizer INC. | $49.37 | 2021-2023 | |
| Abbvie INC. | $41.09 | 2022-2025 | |
| Hikma Pharmaceuticals USA | $36.32 | 2021-2024 | Ryaltris |
| Adlon Therapeutics L.P. | $36.20 | 2021 | |
| Daiichi Sankyo INC. | $34.45 | 2021-2022 | |
| Phadia US INC. | $34.45 | 2019-2023 | Immunocap |
| Alexion Pharmaceuticals, INC. | $32.74 | 2023 | Strensiq |
| Eisai INC. | $29.95 | 2022 | |
| Abbott Laboratories | $26.67 | 2024 | Id Now Strep A 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.37 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.85 | 2019-2020 | |
| Cipher Pharmaceuticals US LLC | $21.65 | 2025 | Spinosad, Natroba |
| Genentech USA, INC. | $20.00 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2025 | Zoryve |
| Cmp Pharma, INC. | $13.34 | 2022 | |
| Sobi, INC | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liberty Dizon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.